| Literature DB >> 34267996 |
Sisay Abebe Debela1, Ishmail Sheriff2, Endashaw Abebe Debela3, Musa Titus Sesay4, Alemu Tolcha5, Michaela Sia Tengbe6.
Abstract
BACKGROUND: Polychlorinated biphenyls (PCBs) are synthetic and persistent toxic chemicals with a high potential to bioaccumulate in human tissue. There is no existing literature on workers' perceptions and occupational cancer risk due to exposure to PCBs in Ethiopia.Entities:
Keywords: PCB; cancer risk; human health; polychlorinated biphenyls; public perception
Year: 2021 PMID: 34267996 PMCID: PMC8276727 DOI: 10.5696/2156-9614-11.30.210609
Source DB: PubMed Journal: J Health Pollut ISSN: 2156-9614
Figure 2Map of nine study area sampling sites in Addis Ababa, Ethiopia44
Slope Factor of Polychlorinated Biphenyl Congeners for Ingestion (SFO (mg/kg-day)−1, Dermal Contact (SFO × GIABS (mg/kg-day)−1), Inhalation (mg/m3)−1) and Dermal Absorption Factors54
| 189 | 3.9E+00 | 1.1E-03 | 2.3E-05 | 1.3E-03 | 0.14 |
| 167 | 3.9E+00 | 1.1E-03 | 2.3E-05 | 1.3E-03 | 0.14 |
| 157 | 3.9E+00 | 1.1E-03 | 2.3E-05 | 1.3E-03 | 0.14 |
| 156 | 3.9E+00 | 1.1E-03 | 2.3E-05 | 1.3E-03 | 0.14 |
| 169 | 3.9E+03 | 1.1E+00 | 2.3E-08 | 1.3E-06 | 0.14 |
| 123 | 3.9E+00 | 1.1E-03 | 2.3E-05 | 1.3E-03 | 0.14 |
| 118 | 3.9E+00 | 1.1E-03 | 2.3E-05 | 1.3E-03 | 0.14 |
| 105 | 3.9E+00 | 1.1E-03 | 2.3E-05 | 1.3E-03 | 0.14 |
| 114 | 3.9E+00 | 1.1E-03 | 2.3E-05 | 1.3E-03 | 0.14 |
| 126 | 1.3E+04 | 3.8E+00 | 7.0E-09 | 4.0E-07 | 0.14 |
| 77 | 1.3E+01 | 3.8E-03 | 7.0E-06 | 4.0E-04 | 0.14 |
| 81 | 3.9E+01 | 1.1E-02 | 2.3E-06 | 1.3E-04 | 0.14 |
| Non DL-PCBs | 2.0E+00 | 5.7E-04 | 0.14 |
Abbreviation: Non DL-PCBs: Non-dioxin-like polychlorinated biphenyls
Note: Reference dose (RfD): estimate (with uncertainty spanning perhaps an order of magnitude) of daily oral exposure to the human population (including sensitive subgroups) that is likely to be without an appreciable risk of deleterious effects during a lifetime.51 Reference concentration (RfC): estimate (with uncertainty spanning perhaps an order of magnitude) of continuous inhalation exposure to the human population (including sensitive subgroups) that is likely to be without appreciable risk of deleterious effects during a lifetime.51
Variables Used to Estimate Lifetime Cancer Risk23, 51–52, 55–59
| Ingestion rate (IR) | (mg/day) | 100 |
| Exposed skin area (SA) | (cm2) | 3300 |
| Skin adherence factor (AFsoii) | (mg/cm2) | 0.2 |
| Exposure frequency (EF) | (days/year) | 313 |
| Exposure duration (ED) | (year) | 25 |
| Exposure time (ET) | (h/day) | 8 |
| Body weight (BW) | (kg) | 60 |
| Averaging time (AT) = (70 years × 365 days/year) | (days) | 25,550 |
| Averaging time AT* = (70 years × 365 days/year × 24 h/day) | (h) | 613,200 |
Polychlorinated Biphenyl Concentration Congeners Across Study Sites (mg kg−1 dw)44
| 2.15 | 0.214 | 0.23 | 0.0721 | 0.195 | 0.473 | 0.459 | 0.0445 | 0.505 | |
| 1.71 | 0.23 | 0.153 | 0.104 | 0.151 | 0.171 | 0.442 | 0.116 | 0.177 | |
| 0.0785 | 0.0195 | 0.0139 | 0.0671 | 0.00302 | 0.0202 | 0.0077 | 0.00601 | 0.0042 | |
| 0.175 | 0.21 | 0.147 | 0.19 | 0.127 | 0.214 | 0.0988 | 0.0813 | 0.173 | |
| 0.132 | 0.183 | 0.149 | 0.103 | 0.08 | 0.114 | 0.0691 | 0.0729 | 0.183 | |
| 0.0152 | 0.0172 | 0.0339 | 0.303 | 0.0252 | 0.0838 | 0.0512 | 0.0246 | 0.0217 | |
| 0.0262 | 4.38E-3 | 0.0124 | 0.184 | 0.00751 | ND | 0.0251 | 0.0259 | 0.00634 | |
| 0.0358 | 0.0228 | 0.0168 | 0.202 | 0.0109 | 0.0627 | 0.0168 | 0.0122 | 0.0247 | |
| 0.0662 | 0.0491 | 0.0113 | 0.0756 | 0.0445 | 0.044 | 0.0268 | 0.0351 | 0.0398 | |
| ND | 0.0162 | 0.0293 | 0.185 | 0.0125 | 0.265 | 0.0665 | 0.00253 | 0.0235 | |
| 0.0828 | 0.0576 | 0.00498 | 0.152 | 0.0323 | 0.0949 | 0.0449 | 0.0294 | 0.0158 | |
| ND | 0.0259 | 0.0759 | 0.123 | 0.0416 | 0.0404 | 0.0221 | 0.0294 | 0.0822 | |
| 0.038 | 0.0279 | 0.0122 | 0.133 | 0.00655 | 0.0719 | 0.0631 | 0.13 | 0.0653 | |
| 0.0407 | 0.0201 | 0.0275 | 0.038 | 0.00872 | 0.0556 | 0.0774 | 0.0774 | 0.146 | |
| 0.0462 | 0.0122 | 0.00186 | 0.033 | 0.0534 | 0.078 | 0.0247 | 0.147 | 0.187 | |
| ND | ND | 0.00438 | 0.0238 | 0.0404 | 0.0439 | 0.0234 | 0.147 | 0.187 | |
| 0.0944 | 0.0518 | 0.0757 | 0.0888 | 0.0189 | 0.0737 | 0.0972 | 0.0896 | 0.256 | |
| 0.171 | 0.163 | 0.137 | 0.0208 | 0.169 | 0.00191 | 0.00422 | 0.00593 | 0.018 |
ND: Non-detected PCBs
Perception of the Association of the Impact of PCBs on Humans and the Environment Across Occupational Exposure Variables
| Use of personal protective equipment | Yes | 78 (29.5%) | 51 (19.3%) | 49.15 | |
| No | 36 (13.6%) | 99 (37.6%) | |||
| Training on hazardous chemicals | Yes | 51 (19.3%) | 5 (1.8%) | 32.58 | |
| No | 105 (39.8%) | 103 (39.1%) | |||
| Leakage of oil from pipeline | Yes | 129 (48.9%) | 94 (35.6%) | 7.85 | |
| No | 11 (4.1%) | 30 (11.4%) | |||
| Spillage of oil in workshop areas | Yes | 195 (73.9%) | 22 (8.4) | 3.17 | 0.087 |
| No | 8 (3%) | 39 (14.7%) | |||
| Presence of other electric industries in study area | Yes | 116 (43.9%) | 65 (24.6%) | 2.11 | 0.152 |
| No | 51 (19.3%) | 32 (12.1%) | |||
| Emissions from workshop | Yes | 148 (46%) | 43 (16.3%) | 1.98 | 0.243 |
| No | 46 (17.4%) | 27 (10.2%) | |||
| Dump site protection | Yes | 59 (22.3%) | 32 (12.1) | 27.43 | |
| No | 139 (52.7%) | 34 (12.9%) | |||
Abbreviation: PCBs-Polychlorinated biphenyls
** Significant difference at
Human Cancer Risk in Humans via Ingestion, Dermal Contact and Inhalation of Soil Particles Across Sampling Sites
| 1 | 2.392E-05 | 0 | 3.54E-04 | 0 | 8.021E-12 | 8.229E-08 | |||
| 2 | 1.780E-05 | 3.96E-05 | 2.4E-04 | 6.609E-09 | 2.315E-11 | 8.191E-09 | |||
| 3 | 4.547E-06 | 2.03E-05 | 2.57E-04 | 1.937E-08 | 8.147E-11 | 8.803E-09 | |||
| 4 | 2.173E-05 | 1.10E-04 | 1.14E-04 | 3.139E-08 | 8.147E-11 | 8.803E-09 | |||
| 5 | 2.949E-05 | 5.93E-05 | 2.17E-04 | 1.062E-08 | 7.463E-11 | 7.463E-09 | |||
| 6 | 1.844E-05 | 1.73E-05 | 6.78E-04 | 1.031E-08 | 8.147E-11 | 1.810E-08 | |||
| 7 | 7.515E-06 | 3.82E-05 | 5.17E-04 | 5.639E-09 | 8.147E-11 | 1.756E-08 | |||
| 8 | 1.056E-05 | 2.79E-05 | 3.86E-04 | 7.502E-09 | 8.147E-11 | 1.703E-09 | |||
| 9 | 1.442E-05 | 5.74E-05 | 7.06E-04 | 2.316 | 2.098E-08 | 8.147E-11 | 1.932E-09 | ||
Note: Bold indicates potential cancer risk [all cancer risks are presented in units of 10−3 except 0 values at the 10th centile]
Lifetime Cancer Risk via Dermal Contact/Absorption Pathway Across Study Sites
| 28 | 9.9E-07 | 9.1E-07 | 2.1E-07 | ||||||
| 51 | 7.1E-07 | 7.1E-07 | 7.0E-07 | 7.9E-07 | 5.4E-07 | 8.2E-07 | |||
| 77 | |||||||||
| 81 | |||||||||
| 101 | 3.6E-07 | 9.1E-08 | 6.5E-08 | 6.5E-08 | 1.4E-08 | 9.4E-08 | 3.6E-08 | 2.8E-08 | 1.9E-08 |
| 105 | 0.0E+00 | 1.5E-07 | 2.7E-07 | 1.1E-07 | 6.0E-07 | 2.3E-08 | 2.1E-07 | ||
| 114 | 3.2E-07 | 2.1E-07 | 1.5E-07 | 9.9E-08 | 5.7E-07 | 1.5E-07 | 1.1E-07 | 2.2E-07 | |
| 118 | 2.4E-07 | 4.0E-08 | 1.1E-07 | 6.8E-08 | 0.0E+00 | 2.3E-07 | 2.3E-07 | 5.7E-08 | |
| 123 | 1.4E-07 | 1.6E-07 | 3.1E-07 | 2.3E-07 | 7.6E-07 | 4.6E-07 | 2.2E-07 | 2.0E-07 | |
| 126 | 0.0E+00 | 8.9E-04 | |||||||
| 138 | 1.2E-07 | 2.7E-07 | 2.3E-08 | 7.1E-07 | 1.5E-07 | 4.4E-07 | 2.1E-07 | 1.4E-07 | 7.3E-08 |
| 153 | 3.1E-07 | 2.3E-07 | 5.2E-08 | 3.5E-07 | 2.1E-07 | 2.0E-07 | 1.2E-07 | 1.6E-07 | 1.8E-07 |
| 156 | 3.7E-07 | 1.8E-07 | 2.5E-07 | 3.4E-07 | 7.9E-08 | 5.0E-07 | 7.0E-07 | 7.0E-07 | |
| 157 | 4.2E-07 | 1.1E-07 | 1.7E-08 | 3.0E-07 | 4.8E-07 | 7.1E-07 | 2.2E-07 | ||
| 167 | 3.4E-07 | 2.5E-07 | 1.1E-07 | 5.9E-08 | 6.5E-07 | 5.7E-07 | 5.9E-07 | ||
| 169 | 6.7E-04 | 2.3E-03 | |||||||
| 180 | 0.0E+00 | 0.0E+00 | 2.0E-08 | 1.1E-07 | 1.9E-07 | 2.0E-07 | 1.1E-07 | 6.8E-07 | 8.7E-07 |
| 189 | 1.9E-07 | 1.7E-08 | 3.8E-08 | 5.4E-08 | 1.6E-07 | ||||
| Total risk | 9.0E-04 | 1.3E-03 | 3.0E-03 | 4.5E-03 | 1.4E-03 | 1.9E-03 | 1.6E-03 | 1.7E-03 | 4.8E-03 |
Abbreviation: PCB-Polychlorinated biphenyl
Note: Bold indicates potential cancer risk
Lifetime Cancer Risk via Accidental Ingestion Pathway Across Study Sites
| 28 | 2.0E-07 | 2.1E-07 | 2.1E-07 | 1.8E-07 | 4.3E-07 | 4.2E-07 | 4.1E-08 | 4.6E-07 | |
| 51 | 2.1E-07 | 1.4E-07 | 1.4E-07 | 1.4E-07 | 1.6E-07 | 4.0E-07 | 1.1E-07 | 1.6E-07 | |
| 77 | |||||||||
| 81 | |||||||||
| 101 | 7.2E-08 | 1.8E-08 | 1.3E-08 | 1.3E-08 | 2.8E-09 | 1.8E-08 | 7.0E-09 | 5.5E-09 | 3.8E-09 |
| 105 | |||||||||
| 114 | |||||||||
| 118 | |||||||||
| 123 | |||||||||
| 126 | |||||||||
| 138 | 2.4E-08 | 5.3E-08 | 4.5E-09 | 1.4E-07 | 2.9E-08 | 8.7E-08 | 4.1E-08 | 2.7E-08 | 1.4E-08 |
| 153 | 6.0E-08 | 4.5E-08 | 1.0E-08 | 6.9E-08 | 4.1E-08 | 4.0E-08 | 2.4E-08 | 3.2E-08 | 3.6E-08 |
| 156 | |||||||||
| 157 | |||||||||
| 167 | |||||||||
| 169 | |||||||||
| 180 | 0.0E+00 | 0.0E+00 | 4.0E-09 | 2.2E-08 | 3.7E-08 | 4.0E-08 | 2.1E-08 | 1.3E-07 | 1.7E-07 |
| 189 | 3.0E-07 | 2.9E-07 | 2.4E-07 | 3.7E-08 | 3.0E-07 | 3.4E-09 | 7.5E-09 | 1.1E-08 | 3.2E-08 |
| Total risk | 3.8E-05 | 4.2E-05 | 2.9E-05 | 3.8E-05 | 2.6E-05 | 4.3E-05 | 2.0E-05 | 1.6E-05 | 3.5E-05 |
Abbreviation: PCB-Polychlorinated biphenyl
Note: Bold indicates potential cancer risk
Lifetime Cancer Risk Via Inhalation Exposure Pathway Across Study Sites
| 28 | 8.2E-11 | 8.2E-12 | 8.8E-12 | 8.8E-12 | 7.5E-12 | 1.8E-11 | 1.8E-11 | 1.7E-12 | 1.9E-11 |
| 51 | 6.5E-11 | 8.8E-12 | 5.9E-12 | 5.9E-12 | 5.8E-12 | 6.5E-12 | 1.7E-11 | 4.4E-12 | 6.8E-12 |
| 77 | 3.4E-14 | 3.4E-14 | 3.4E-14 | 3.4E-14 | 3.4E-14 | 3.4E-14 | 3.4E-14 | 3.4E-14 | 3.4E-14 |
| 81 | 1.3E-13 | 1.3E-13 | 1.3E-13 | 1.3E-13 | 1.3E-13 | 1.3E-13 | 1.3E-13 | 1.3E-13 | 1.3E-13 |
| 101 | 3.0E-12 | 7.5E-13 | 5.3E-13 | 5.3E-13 | 1.2E-13 | 7.7E-13 | 2.9E-13 | 2.3E-13 | 1.6E-13 |
| 105 | 0.0E+00 | 1.2E-15 | 2.2E-15 | 1.4E-14 | 9.2E-16 | 2.0E-14 | 4.9E-15 | 1.9E-16 | 1.7E-15 |
| 114 | 2.6E-15 | 2.6E-15 | 2.6E-15 | 2.6E-15 | 2.6E-15 | 2.6E-15 | 2.6E-15 | 2.6E-15 | 2.6E-15 |
| 118 | 1.9E-15 | 1.9E-15 | 1.9E-15 | 1.9E-15 | 1.9E-15 | 1.9E-15 | 1.9E-15 | 1.9E-15 | 1.9E-15 |
| 123 | 1.1E-15 | 1.1E-15 | 1.1E-15 | 1.1E-15 | 1.1E-15 | 1.1E-15 | 1.1E-15 | 1.1E-15 | 1.1E-15 |
| 138 | 1.0E-12 | 2.2E-12 | 1.9E-13 | 5.8E-12 | 1.2E-12 | 3.6E-12 | 1.7E-12 | 1.1E-12 | 6.0E-13 |
| 153 | 2.5E-12 | 1.9E-12 | 4.3E-13 | 2.9E-12 | 1.7E-12 | 1.7E-12 | 1.0E-12 | 1.3E-12 | 1.5E-12 |
| 126 | 0.0E+00 | 6.6E-12 | 1.9E-11 | 3.1E-11 | 1.1E-11 | 1.0E-11 | 5.6E-12 | 7.5E-12 | 2.1E-11 |
| 156 | 3.0E-15 | 3.0E-15 | 3.0E-15 | 3.0E-15 | 3.0E-15 | 3.0E-15 | 3.0E-15 | 3.0E-15 | 3.0E-15 |
| 157 | 3.4E-15 | 3.4E-15 | 3.4E-15 | 3.4E-15 | 3.4E-15 | 3.4E-15 | 3.4E-15 | 3.4E-15 | 3.4E-15 |
| 167 | 2.8E-15 | 2.8E-15 | 2.8E-15 | 2.8E-15 | 2.8E-15 | 2.8E-15 | 2.8E-15 | 2.8E-15 | 2.8E-15 |
| 180 | 0.0E+00 | 0.0E+00 | 1.7E-13 | 9.1E-13 | 1.5E-12 | 1.7E-12 | 9.0E-13 | 5.6E-12 | 7.2E-12 |
| 169 | 7.0E-12 | 7.0E-12 | 7.0E-12 | 7.0E-12 | 7.0E-12 | 7.0E-12 | 7.0E-12 | 7.0E-12 | 7.0E-12 |
| 189 | 1.3E-14 | 1.3E-14 | 1.3E-14 | 1.3E-14 | 1.3E-14 | 1.3E-14 | 1.3E-14 | 1.3E-14 | 1.3E-14 |
| Total risk | 1.6E-10 | 3.6E-11 | 4.3E-11 | 6.3E-11 | 3.6E-11 | 5.0E-11 | 5.1E-11 | 2.9E-11 | 6.4E-11 |
Abbreviation: PCB-Polychlorinated biphenyl
Distribution of Perception of the Impact of PCBs on Humans and the Environment with Sociodemographic Characteristics
| Sex | Male | 82 (31%) | 58 (22%) |
| Female | 83 (31.5%) | 41 (15.5%) | |
| Education level | Secondary school | 21 (8%) | 12 (4.5%) |
| Certificate (10+1) | 44 (16.7%) | 22 (8.4%) | |
| Diploma (10+3) | 53 (20.1%) | 19 (7.1%) | |
| First degree and above | 81 (30.6%) | 12 (4.5%) | |
Abbreviation: PCBs-Polychlorinated biphenyls